Cited by 40Ferroptosis and cancer prognosisRadiation Therapy and DosimetryNanoplatforms for cancer theranostics

Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions

Open access
Tan, Xin, Huang, Xiang, Niu, Baolong, Guo, Xingdong, Lei, Xiao, Qu, Baolin·2022·Frontiers in Molecular Biosciences

Abstract

Radiotherapy is applied in about 70% patients with tumors, yet radioresistance of tumor cells remains a challenge that limits the efficacy of radiotherapy. Ferroptosis, an iron-dependent lipid peroxidation regulated cell death, is involved in the development of a variety of tumors. Interestingly, there is evidence that ferroptosis inducers in tumor treatment can significantly improve radiotherapy sensitivity. In addition, related studies show that Glutathione S-transferase P1 (GSTP1) is closely related to the development of ferroptosis. The potential mechanism of targeting GSTP1 to inhibit tumor cells from evading ferroptosis leading to radioresistance has been proposed in this review, which implies that GSTP1 may play a key role in radiosensitization of lung cancer via ferroptosis pathway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmolb.2022.1102158

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some GST family members have been shown to inhibit ferroptosis in lung, pancreatic, and gastric cancers.

    “Some GST family members have been shown to inhibit ferroptosis in lung, pancreatic, and gastric cancers (57–59).”

    From The origin of hepatocellular carcinoma depends on metabolic zonation (2026) · cites this paper as [57]

    The Perspective (page unavailable) reports that GSTM1 inhibits ferroptosis in brain metastases from lung cancer. It presents GSTP1’s role in lung cancer as a hypothesis, however, and the passages addressing pancreatic and gastric cancer do not establish GST-mediated inhibition of ferroptosis in either. Thus the source supports the lung-cancer portion, but not the full three-cancer claim. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tan, X., Huang, X., Niu, B., Guo, X., Lei, X., & Qu, B.
Affiliations
Chinese PLA General Hospital (CN)
Corresponding author
  • Lei, Xiao
  • Qu, Baolin
Venue
Frontiers in Molecular Biosciences
Published
2022-12-16
Volume
9
Pages
1102158-1102158
ISSN
2296-889X (ISSN-L)
OpenAlex
W4313271750
Cited by
40
References
97
Citations by year
2026: 5 · 2025: 13 · 2024: 19 · 2023: 3
FWCI
1.51
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Molecular Biosciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (20BJZ40 82003387)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Radiation Therapy and Dosimetry
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
ferroptosis, GSTP1, glutathione S-transferase pi, lung cancer, radiotherapy, radioresistance (biology), radiosensitization, lipid peroxidation, iron-dependent cell death, ferroptosis inducers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review